Ivan Grishagin
- Co-authors
- Bogdan OlenyukVladimir E. NebolsinFedor N. NovikovMaria V. PanovaÐắc-Trung NguyễnЕ. Д. БаздыревNoel SouthallPolina Rusina
- Topics
- Computational Drug Discovery Methods (4 papers)Bioinformatics and Genomic Networks (3 papers)Genomics and Rare Diseases (2 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Clinical Oncology
- Partner nations
- United StatesUnited KingdomRussia
In The Last Decade
Ivan Grishagin
16 papers receiving 797 citations
Peers
Comparison fields: 5 of 126
- Molecular Biology 348
- Organic Chemistry 110
- Pulmonary and Respiratory Medicine 103
- Oncology 91
- Immunology 84
Countries citing papers authored by Ivan Grishagin
This map shows the geographic impact of Ivan Grishagin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Grishagin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Grishagin more than expected).
Fields of papers citing papers by Ivan Grishagin
This network shows the impact of papers produced by Ivan Grishagin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Grishagin. The network helps show where Ivan Grishagin may publish in the future.
Co-authorship network of co-authors of Ivan Grishagin
This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Grishagin. A scholar is included among the top collaborators of Ivan Grishagin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Grishagin. Ivan Grishagin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | 10 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 36 | |
| 7 | 119 | |
| 8 | 26 | |
| 9 | 176 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 14 | |
| 13 | Mebendazole: A candidate FDA approved drug for repurposing in leukaemia | 2 |
| 14 | 175 | |
| 15 | 89 | |
| 16 | 89 |
About Ivan Grishagin
Ivan Grishagin is a scholar working on Cancer Research, Computational Theory and Mathematics and Biophysics, having authored 16 papers that have together received 808 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Bioinformatics and Genomic Networks (3 papers) and Genomics and Rare Diseases (2 papers). The work is most often cited by research in Biophysics (40 citations), Health Informatics (8 citations) and Molecular Biology (348 citations). Ivan Grishagin has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Bogdan Olenyuk, Vladimir E. Nebolsin, Fedor N. Novikov, Maria V. Panova, Ðắc-Trung Nguyễn, Е. Д. Баздырев, Noel Southall, Polina Rusina, Ajit Jadhav and Hanah Mesallati. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.